MPM Capital has raised $400 million for its seventh venture fund BioVentures 2018. MPM focuses on companies that develop therapies "to treat severe unmet medical needs."
3 min read · 21 February 2019
Poshmark, a social commerce platform for retailers and shoppers, has appointed tennis champion and businesswoman Serena Williams to its board of directors. In addition to her winning record as a top tennis player, last year Williams launched her own clothing line, SERENA. Poshmark's backers include Mayfield, Menlo Ventures, GGV Capital, Temasek, Inventus Capital, Uncork Capital, Union Grove Venture Partners, Shea Ventures and AngelList.
3 min read · 20 February 2019
Beamery, an HR recruitment software provider, has secured an undisclosed amount of funding. The investor was Workday Ventures.
1 min read · 20 February 2019
Lindon, Utah-based Opiniion Inc, an automated tool for businesses to collect authentic real-time feedback from customers, has raised an undisclosed amount of funding. The investors included BitWealth.
1 min read · 20 February 2019
New York-based StayTuned, a distribution platform for video creators, has raised $2.5 million in funding, according to a blog post on its site. Bowery Capital led the round.
1 min read · 20 February 2019
Sunnyvale, California-based Armorblox, a provider of a "natural language understanding platform," has closed $16.5 million in Series A funding. General Catalyst led the round.
1 min read · 20 February 2019
San Jose, California-based K2 Cyber Security Inc, a cloud workload protection platform, has secured $6 million in seed funding. The backers were GreatPoint Ventures and Embark Ventures.
4 min read · 20 February 2019
Vincross, a consumer robotics maker, has secured $10 million in funding. Lenovo led the round with participation from other backers that included GGV Capital and Seek Dource.
1 min read · 20 February 2019
ViSenze, a image recognition startup, has raised $20 million in Series C funding. Gobi Partners and Sonae IM led the round.
1 min read · 20 February 2019
Calypso Biotech, a Dutch developer of therapeutic antibodies for autoimmune diseases, has secured 20 million euros in Series A financing. The lead backers were Gilde Healthcare and Inkef Capital.
1 min read · 20 February 2019